Mendelian randomization reveals immune cell composition as a key determinant of cervical cancer prognosis

Cervical cancer is still a major public health problem, and understanding the complex interplays in the tumor microenvironment is essential to implementing better clinical outcome measures. In this study, we used a Mendelian Randomization-based strategy to assess the causal roles of immune cell composition and disease prognosis in cervical cancer.

The authors employed genetic natural experiments to measure the relationship between monocyte absolute counts, CD4-CD8-T cell ratios, and CD24 levels on memory B cells and indicators of cervical cancer prognosis.

Mendelian Randomization analysis showed that higher monocyte absolute counts were associated with a better prognosis, implying a protective role of these cells. In contrast, compared to individuals with good prognosis, high CD4-CD8-T cell ratios and low CD24 expression on memory B cells associated with bad prognosis suggest a risk-promoting role of these immune cell subsets. These observations were also further supported by additional analyses, such as scatter plots and linear regression models, which revealed further nuances in the intricate relationship between the immune microenvironment and the disease.

Our study utilizing the Mendelian Randomization approach provides novel insights into the causal relationships between the immune microenvironment of cervical cancer and its prognosis. The identified immune cell markers (monocyte counts, T cell ratios) have the potential to serve as prognostic biomarkers and to inform the design of targeted immunotherapeutic approaches in cervical cancer.